These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 4160834)
1. 6-alpha-methyl- 17-alpha-hydroxyprogesterone acetate as a chemotherapeutic agent in adenocarcinoma of the uterus. Bonte JB; Drochmans A; Ide P Acta Obstet Gynecol Scand; 1966; 45(1):121-9. PubMed ID: 4160834 [No Abstract] [Full Text] [Related]
2. [Preliminary trials of medical treatment of adenocarcinoma of the endometrium]. Noci L; Cattaneo A; Ottaviano M Minerva Ginecol; 1971 Oct; 23(19):773-6. PubMed ID: 5157602 [No Abstract] [Full Text] [Related]
6. The histological changes produced in untreated adeno-carcinoma of the endometrium by a progestogen. Hudson CN; Stansfeld AG J Obstet Gynaecol Br Commonw; 1967 Jun; 74(3):442-4. PubMed ID: 6026619 [No Abstract] [Full Text] [Related]
7. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS Gynecol Oncol; 1985 Feb; 20(2):139-55. PubMed ID: 3972284 [TBL] [Abstract][Full Text] [Related]
8. [Progestins in combined treatment of endometrial cancer]. Voznyĭ EK; Titova VA Sov Med; 1990; (9):102-7. PubMed ID: 2148437 [No Abstract] [Full Text] [Related]
10. [Synthetic progestins in combined treatment of cancer of the uterine body]. Iatskovskai NL Vopr Onkol; 1976; 22(3):25-8. PubMed ID: 936523 [TBL] [Abstract][Full Text] [Related]
11. Short-term progestogen treatment of endometrial carcinoma. Histological, histochemical and hormonal studies. Moe N Acta Obstet Gynecol Scand; 1972; 51(1):55-62. PubMed ID: 4261828 [No Abstract] [Full Text] [Related]
12. Endometrial carcinoma in Stein-Leventhal syndrome treated with hydroxyprogesterone caproate. Eddy WA Am J Obstet Gynecol; 1978 Jul; 131(5):581-2. PubMed ID: 677198 [No Abstract] [Full Text] [Related]
13. [Effect of adjuvant hormonotherapy on the results of the radiation treatment of patients with cancer of the corpus uteri]. Bokhman IaV; Stoliarova IV; Gastev AIu Vopr Onkol; 1987; 33(4):49-52. PubMed ID: 3296435 [TBL] [Abstract][Full Text] [Related]
14. Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma. Piver MS; Barlow JJ; Lurain JR; Blumenson LE Cancer; 1980 Jan; 45(2):268-72. PubMed ID: 6985833 [TBL] [Abstract][Full Text] [Related]
15. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate. Reifenstein EC Gynecol Oncol; 1974 Aug; 2(2-3):377-414. PubMed ID: 4616884 [No Abstract] [Full Text] [Related]
16. [Combined morphologic evaluation of the efficacy of progestin therapy of primary endometrial cancer]. Shvedova LA; Botnar' ER; Shendereva TS; Volostnykh LV; Chernyĭ AP Vopr Onkol; 1984; 30(3):40-4. PubMed ID: 6710947 [TBL] [Abstract][Full Text] [Related]
17. [Hormofort in the treatment of metastatic adenocarcinoma of corpus uteri]. Kaliński R; Wlodarski A Wiad Lek; 1972 Oct; 25(20):1903-5. PubMed ID: 4643245 [No Abstract] [Full Text] [Related]
18. A randomized trial of adjuvant progestagen in early endometrial cancer. Vergote I; Kjørstad K; Abeler V; Kolstad P Cancer; 1989 Sep; 64(5):1011-6. PubMed ID: 2667746 [TBL] [Abstract][Full Text] [Related]
19. Progesterone caproate in the treatment of endometrial cancer. Sherman AI Obstet Gynecol; 1966 Sep; 28(3):309-14. PubMed ID: 4162030 [No Abstract] [Full Text] [Related]
20. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment]. Shenderëva TS; Shvedova LA Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]